SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences - Quaterly Results

28 Jan 2026 Evaluate
The quarter ended December 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1800.30 millions.Net Profit of the company move down -36.64% to Rs. 221.30  millions from Rs. 349.30 millions  in the same quarter last year.A decline of 431.70 millions was observed in the OP in the quarter ended December 2025 from 524.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1800.30 1727.10 4.24 5306.30 5103.40 3.98 6534.30 5820.50 12.26
Other Income 34.10 33.10 3.02 131.80 76.20 72.97 126.80 72.10 75.87
PBIDT 431.70 524.70 -17.72 1274.40 1417.80 -10.11 1723.30 1353.60 27.31
Interest 2.50 1.20 108.33 5.00 4.40 13.64 6.20 4.50 37.78
PBDT 345.00 523.50 -34.10 1297.40 1140.40 13.77 2543.10 1349.10 88.50
Depreciation 53.80 54.60 -1.47 157.40 160.60 -1.99 214.30 170.70 25.54
PBT 291.20 468.90 -37.90 1140.00 979.80 16.35 2328.80 1178.40 97.62
TAX 69.90 119.60 -41.56 287.30 320.90 -10.47 496.40 301.80 64.48
Deferred Tax 0.80 0.40 100.00 11.90 -1.20 -1091.67 -0.50 -23.60 -97.88
PAT 221.30 349.30 -36.64 852.70 658.90 29.41 1832.40 876.60 109.03
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 23.98 30.38 -21.07 24.02 27.78 -13.55 26.37 23.26 13.40

RPG Life Sciences Share Price

1866.55 -26.60 (-1.41%)
13-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.00
Cipla 1211.30
Zydus Lifesciences 920.00
Lupin 2316.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×